Suture, ComplicationNCT05395923
The Effects of Palatal Pre-sutures in Connective Tıssue Graft Surgery
A study testing Suture in people with Suture, Complication and Gingival Recession, run by Biruni University at 1 site in Turkey (Türkiye).
Trial summary
Connective tissue graft operation is one of the most frequently performed surgical procedures to increase the width of the attached gingiva and to treat gingival recessions. The most preferred donor site during this operation is the palatal mucosa.Reported postoperative complications are usually related to the donor… Read more about this study
- Who is it for?
- Ages 19 to 60 yearsHealthy volunteers can take part
- Conditions the study is for
- Suture, Complication, Gingival Recession, Bleeding Hemorrhage
- What is being tested?
- Suture
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 32 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 9 Jan 2023to 29 Jul 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 19 to 60 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- - The patient must be over the age of 18,
- Not having any systemic disease,
- Not receiving chemotherapy or radiotherapy treatment,
- Not using drugs regularly and not being addicted to drugs,
- Not be in pregnancy and/or lactation period,
- Not smoking,
Show all 9Show fewer
- Not having received antibiotic treatment in the last 6 months,
- Presence of Cairo Type 1 or Type 2 recession defect in a single tooth,
- The patient is cooperative.
Who cannot join
- The patient is younger than 18 years old,
- Active infectious disease (acute hepatitis, AIDS, tuberculosis), cancer or any systemic condition that may affect periodontal tissues,
- Receiving chemotherapy or radiotherapy treatment,
- Being on regular medication and being addicted to drugs,
- Patients with a plaque score greater than 20% after phase I treatment (Silness and Löe, 1964),
- Being in pregnancy and/or lactation period,
Show all 9Show fewer
- Being a smoker
- To have been treated with antibiotics in the last 6 months,
- Not being cooperative.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: The Effects of Palatal Pre-sutures on Hemostasis and Patient Comfort in Connective Tıssue Graft Surgery
Connective tissue graft operation is one of the most frequently performed surgical procedures to increase the width of the attached gingiva and to treat gingival recessions. The most preferred donor site during this operation is the palatal mucosa.Reported postoperative complications are usually related to the donor site. Problems such as prolongation of bleeding time, delay in wound healing and severe pain in the palatal region where the graft is taken are frequently encountered. Bleeding control in the palatal donor area is very important for patient comfort. Additional measures may be required to control bleeding, such as sutures with or without hemostatic agents, or acrylic, plastic palatal stents and periodontal pastes prepared before the operation. Suturing the Greater Palatine Artery (GPA) or terminal vessel branches has been shown to be an effective method to control palatal bleeding.
Therefore the aim of this study is to evaluate the effectiveness of the pre-suture method applied in the palatal region before the connective tissue graft is taken in reducing hemostasis.Pre-suture method can increase the operator's field of vision and operational comfort. Patient-reported outcomes such as the amount of pain and bleeding in the palatal donor area during and after surgery, painkiller intake, number of days of discomfort, satisfaction, quality of life, and willingness to be treated will be evaluated.
In addition, it will be evaluated whether this suture technique affects the healing of the half-thickness flap in the palatal region after obtaining a connective tissue graft with a single incision method.
Read the detailed description
Various methods have been described to manage bleeding and/or promote healing of the palatal donor site.These techniques include sutures with or without hemostatic agents, or the use of materials such as acrylic or plastic palatal stents, periodontal seals, and platelet-rich fibrin (PRF) prepared before the operation. The use of an additional hemostatic agent often requires additional surgical time and expense, and most of the techniques described in the literature for the management of palatal hemorrhage are used to control bleeding after it has occurred. GPA and/or suturing of terminal vessel branches is a popular and effective technique to control palatal bleeding.Recently, a detailed protocol for a Greater Palatine Compression Suture (GPCS) has been presented and proposed as a predictable method for controlling bleeding when this suture is applied preoperatively at the palatal donor site. This protocol is based on the estimated location of the greater palatal foramen and vascular bundle and has proven to be efficient in controlling palatal bleeding. The recommended protocol for GPCS is as follows:
- The midpalatal line is defined.
- An imaginary line is joined to the midpalatal line from the midline of the first and second maxillary molars (point X).
- Another point (Point A) is defined along the X line at a distance of 20 mm from the midpalatal line. (Y point)
- The needle is passed through point A along its curve, and the exit point (point B) of the needle should be approximately 10 mm medial and approximately 5 mm anterior to point A. 1/2 diameter, triangular body, 3-0 braided silk sutures recommended in this protocol were used. The effectiveness of GPCS on palatal hemostasis before obtaining a free gingival graft was also evaluated previously. Reduced palatal bleeding is a valuable clinical benefit in terms of reduced perioperative morbidity, better visibility for the operator, reduced need for hemostatic agents, and operation time.
In addition, the availability of such a technique can be reassuring to the operator when removing autogenous grafts and may be of additional importance in patients prone to bleeding. One of the primary results in our study was the amount of perioperative bleeding. Methods of measuring perioperative blood loss include direct volumetric estimation, weighing blood gauze pads, using various formulas based on hematocrit values, and visual estimation. In our study, bloody gauze pads will be measured with precision scales and the amount of bleeding in the palate will be directly measured during the operation.
In our study, it is aimed to evaluate whether the BPKS technique has any effect on the healing of the half-thickness flap in the donor area when applied in connective tissue graft procedures obtained with the single incision method.
Evaluation of donor site wound healing with anamnesis and index records will be performed by a blinded investigator who did not perform the operation (B.K.).
Initial periodontal treatments will be performed for each patient participating in the study before surgical procedures. Oral hygiene, scaling, root planing and occlusal adjustments will be carried out when necessary. Connective tissue graft will be harvested with a single incision method. Surgical procedures will be performed by a single investigator (M.Z.).
At the beginning of the operation, 0.5 mL of 2% lidocaine anesthesia containing 1:200,000 adrenaline will be administered to the palatal donor area to both the control and test groups, from the points corresponding to the canine and the first molar. In the test group, GPCS (Silk, 4-0, 18 mm, 3/8 sharp needle) will be placed before the incision in the palatal region. Then, connective tissue graft will be taken with a single incision technique using a 15-C scalpel in both groups. The thickness of the connective tissue graft to be taken in our study will be 1.5-2 mm, and its dimensions will be 8X8 mm as standard. Then, the half-thickness flap in the palatal region will be closed with a continuous locked suture (Trofilen, 5/0, 16 mm, 3/8 sharp needle). The connective tissue graft will be sutured to the recipient area with 6-0 polyglactin sutures (Pegalak rapid, 13 mm, 3/8 sharp needle) and the flap is shifted coronally (Trofilen, 5/0, 16 mm, 3/8 sharp needle) will be closed with. Measurement of blood loss will be carried out as described above.
There is no study that applies the BPKS technique during the connective tissue graft operation. In addition, patient-reported outcome measures such as painkiller intake, number of days of discomfort, satisfaction, quality of life, and willingness to be treated again, as well as the amount of pain and bleeding of the palatal donor site during and after surgery, were not examined.
The operation period will be started after the incision and will be terminated when the operation is completed. For postoperative care, the patient will be prescribed a mouthwash containing 0.12% chlorhexidine digluconate to be used twice a day for 3 weeks. In addition, analgesic (Flurbiprofen 100 mg film tablet) will be prescribed to be used when they feel pain. After the operation, patients will be asked not to brush the operation area for 2 weeks and patients will be warned to avoid hard chewing. Brushing with a soft brush will be required in the 3rd postoperative week. The suture in the donor area will be removed in the 1st week, and the suture in the recipient area will be removed in the 2nd week postoperatively. GPCS will be taken 1 week after the operation.
Patients will be called for controls on the 3rd day, 1st and 2nd weeks, 1st, 3rd and 6th months after the operation and their measurements will be recorded. The scales evaluated by the patient will be given to the patient after the operation and will be collected when the study is finished. The records that the physician should take after the surgery will always be recorded by a single researcher. The investigator who took the records will not know the surgical technique applied.
- Being tested
- Suture, No Suture CTG -Control
- Medical subject headings
- Gingival Recession, Hemorrhage
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
SutureProcedure or surgery
The pressure application will be applied before the incision on the palate.
No Suture CTG -ControlProcedure or surgery
A graft will be taken from the palate before the procedure is applied.
| Study group | Role | What they receive |
|---|---|---|
| Palatal Pre-Suture (GPCS) | Experimental | In the test group, GPCS (Silk, 4-0, 18 mm, 3/8 sharp needle) will be placed before the incision in the palatal region. GPCS will be taken one week after surgery. Receives: Procedure: Suture |
| No Palatal Suture (No GPCS) - Control | Active comparator | In the control group, no sutures will be applied before graft harvesting from the palate. Receives: Procedure: No Suture CTG -Control |
What is being measured
The primary outcome is the main question the study is designed to answer.
Measuring the Amount of Intra-operative Bleeding with a Precision Balance
In our study, the amount of blood lost will be estimated by using the gauze weight method, which is a method of directly estimating blood loss. All measurements will be made on a 1 g precision digital balance. Sterile gauze swabs will be weighed dry before the operation. The gauze pads that will be used later will be moistened with 10 mL of sterile 0.9 g/L saline solution before starting the procedure and the weight will be measured again. The time from the removal of the connective tissue graft to the end of the operation will be measured and the pre-moistened gauze pads will be used on the palate during this period and will be stored separately and their weight will be measured immediately after the operation is over. In this method, aspiration in the palatal region should be avoided to minimize errors in blood loss measurement.
Measured: During surgery
Reporting of secondary bleeding as present/absent in the 1st postoperative week
Reporting of secondary bleeding as present/absent both by the patient and by the physician in the follow-up appointments in the 1st postoperative weeks
Measured: 1st postoperative week after the operation.
patient discomfort and satisfaction [Oral Health Impact Profile ]
In this evaluation, the Oral Health Impact Profile (OHIP-14) test will be used by marking the patients on the 3rd postoperative day.
Likert response system in the evaluation of the OHIP14 scale:
0: "never",
- "very little"
- "sometimes"
- "quite often"
- is rated as "often". The total score of the answers given by the participant to each item is evaluated by calculating.
The total score is minimum 0, maximum 56. It is concluded that as the total score increases, the severity of the problem increases and the quality of life decreases.
Measured: On the 3rd day after the operation.
Evaluation of the pain felt by the patients after the operation with Visual Analogue Scale
Pain scores will be recorded on the postoperative 3rd day. It is determined by the patient's assessment of the intensity of pain felt on a scale from 0 to 10.
0: No pain, 10: There is unbearable pain.
Measured: 3rd day after the operation.
Reporting of secondary bleeding as present/absent in the 2nd postoperative week
Reporting of secondary bleeding as present/absent both by the patient and by the physician in the follow-up appointments in the 2nd postoperative weeks
Measured: 2nd postoperative week after the operation.
patient discomfort and satisfaction [Oral Health Impact Profile ]
In this evaluation, the Oral Health Impact Profile (OHIP-14) test will be used by marking the patients on the 1st postoperative week.
Likert response system in the evaluation of the OHIP14 scale:
0: "never",
- "very little"
- "sometimes"
- "quite often"
- is rated as "often". The total score of the answers given by the participant to each item is evaluated by calculating.
The total score is minimum 0, maximum 56. It is concluded that as the total score increases, the severity of the problem increases and the quality of life decreases.
Measured: 1st week after the operation.
patient discomfort and satisfaction [Oral Health Impact Profile ]
In this evaluation, the Oral Health Impact Profile (OHIP-14) test will be used by marking the patients on the 2nd postoperative week.
Likert response system in the evaluation of the OHIP14 scale:
0: "never",
- "very little"
- "sometimes"
- "quite often"
- is rated as "often". The total score of the answers given by the participant to each item is evaluated by calculating.
The total score is minimum 0, maximum 56. It is concluded that as the total score increases, the severity of the problem increases and the quality of life decreases.
Measured: 2nd week after the operation.
patient discomfort and satisfaction [Oral Health Impact Profile ]
In this evaluation, the Oral Health Impact Profile (OHIP-14) test will be used by marking the patients on the 4th postoperative week.
Likert response system in the evaluation of the OHIP14 scale:
0: "never",
- "very little"
- "sometimes"
- "quite often"
- is rated as "often". The total score of the answers given by the participant to each item is evaluated by calculating.
The total score is minimum 0, maximum 56. It is concluded that as the total score increases, the severity of the problem increases and the quality of life decreases.
Measured: 4th week after the operation.
Evaluation of the pain felt by the patients after the operation with Visual Analogue Scale
Pain scores will be recorded on the postoperative 1st week by marking the Visual Analogue Scale (VAS). It will be determined on a scale from 0 (no pain) to 10 (unbearable pain).
It is determined by the patient's assessment of the intensity of pain felt on a scale from 0 to 10.
0: No pain 10: There is unbearable pain
Measured: 1st week after the operation.
Evaluation of the pain felt by the patients after the operation with Visual Analogue Scale.
Pain scores will be recorded on the postoperative 2nd week by marking the Visual Analogue Scale (VAS). It will be determined on a scale from 0 (no pain) to 10 (unbearable pain).
It is determined by the patient's assessment of the intensity of pain felt on a scale from 0 to 10.
0: No pain, 10: There is unbearable pain.
Measured: 2nd week after the operation.
Evaluation of the pain felt by the patients after the operation with Visual Analogue Scale
Pain scores will be recorded on the postoperative 4th week by marking the Visual Analogue Scale (VAS). It will be determined on a scale from 0 (no pain) to 10 (unbearable pain).
It is determined by the patient's assessment of the intensity of pain felt on a scale from 0 to 10.
0: No pain, 10: There is unbearable pain.
Measured: 4th week after the operation.
Secondary outcomes (8)
Evaluation of palatal wound healing by measuring the Early Wound Healing Index in the first 3 months after the operation
Early Wound Healing Score (EHS): After the operation, the wound area will be evaluated with EHS on the 3rd day. The EWHS consists of three parameters:
- Clinical signs of re-epithelialization: -Converged incision edges: 6 points, - Contact incision edges: 3 points, - Visible distance between incision edges: will be evaluated as 0 points.
- Clinical signs of hemostasis: - Absence of fibrin at the incision margins: 2 points, - Presence of fibrin at the incision margins: 1 point, - Bleeding at incision margins: 0 points C) Clinical signs of inflammation: - Absence of redness throughout the incision: 2 points, - Redness involving <50% of the incision length: 1 point, - Redness and/or significant swelling involving >50% of the incision length: 0 points. For ideal wound healing, all scores in A, B, and C are added together and the highest score of 10 is considered as the best healing, and the score of 0 for the worst wound healing.
Measured: 3rd day after surgery.
Findings of necrosis on the donor area
Evaluation by the patient by conducting a survey as yes/no
Measured: During and first 3 months after surgery
Findings of healing with complications on the donor area
Evaluation by the patient by conducting a survey as yes/no
Measured: During and first 3 months after surgery
Evaluation of palatal wound healing by measuring the Early Wound Healing Index
Early Wound Healing Score (EHS) :After the operation, the wound area will be evaluated with EHS on the 1st week after surgery. The EHS consists of three parameters:
- Clinical signs of re-epithelialization: -Converged incision edges: 6 points, - Contact incision edges: 3 points, - Visible distance between incision edges: will be evaluated as 0 points.
- Clinical signs of hemostasis: - Absence of fibrin at the incision margins: 2 points, - Presence of fibrin at the incision margins: 1 point, - Bleeding at incision margins: 0 points C) Clinical signs of inflammation: - Absence of redness throughout the incision: 2 points, - Redness involving <50% of the incision length: 1 point, - Redness and/or significant swelling involving >50% of the incision length: 0 points. For ideal wound healing, all scores in A, B, and C are added together and the highest score of 10 is considered as the best healing, and the score of 0 for the worst wound healing.
Measured: 1st week after surgery.
Evaluation of palatal wound healing by measuring the Early Wound Healing Index
Early Wound Healing Score (EHS) :After the operation, the wound area will be evaluated with EHS on the 2nd week after surgery. The EHS consists of three parameters:
- Clinical signs of re-epithelialization: -Converged incision edges: 6 points, - Contact incision edges: 3 points, - Visible distance between incision edges: will be evaluated as 0 points.
- Clinical signs of hemostasis: - Absence of fibrin at the incision margins: 2 points, - Presence of fibrin at the incision margins: 1 point, - Bleeding at incision margins: 0 points C) Clinical signs of inflammation: - Absence of redness throughout the incision: 2 points, - Redness involving <50% of the incision length: 1 point, - Redness and/or significant swelling involving >50% of the incision length: 0 points. For ideal wound healing, all scores in A, B, and C are added together and the highest score of 10 is considered as the best healing, and the score of 0 for the worst wound healing.
Measured: 2nd week after surgery.
Evaluation of palatal wound healing by measuring the Early Wound Healing Index
Early Wound Healing Score (EHS) :After the operation, the wound area will be evaluated with EHS on the 1st month after surgery. The EHS consists of three parameters:
- Clinical signs of re-epithelialization: -Converged incision edges: 6 points, - Contact incision edges: 3 points, - Visible distance between incision edges: will be evaluated as 0 points.
- Clinical signs of hemostasis: - Absence of fibrin at the incision margins: 2 points, - Presence of fibrin at the incision margins: 1 point, - Bleeding at incision margins: 0 points C) Clinical signs of inflammation: - Absence of redness throughout the incision: 2 points, - Redness involving <50% of the incision length: 1 point, - Redness and/or significant swelling involving >50% of the incision length: 0 points. For ideal wound healing, all scores in A, B, and C are added together and the highest score of 10 is considered as the best healing, and the score of 0 for the worst wound healing.
Measured: 1st month after surgery.
Findings of necrosis on the donor area
Evaluation by the physician by conducting a survey as yes/no
Measured: During and first 3 months after surgery
Findings of healing with complications on the donor area
Evaluation by the physician by conducting a survey as yes/no
Measured: During and first 3 months after surgery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 May 2022
- Study start9 Jan 2023
- Primary completion29 Apr 2024
- Study completion29 Jul 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Suture, ComplicationStudies of the same condition, open and under way.
- More trials run by Biruni UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Investigator
- Enrolment
- 32 participants (actual)
Sponsor and investigators
- Lead sponsor
- Biruni University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Burcu KARADUMAN, Biruni University
- Investigators
- Burcu Karaduman, Principal investigator, bkaraduman@biruni.edu.tr
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05395923
- Sponsor's protocol ID
- 2015-KAEK-58-22-01
- Status last verified
- Jan 2026
- First submitted
- 3 Apr 2022
- Last updated
- 7 Jan 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 7 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effects of Palatal Pre-sutures on Hemostasis and Patient Comfort in Connective Tıssue Graft Surgery
- ClinicalTrials.gov ID
- NCT05395923
- Acronym / sponsor ID
- 2015-KAEK-58-22-01
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 32 participants (actual)
- Lead sponsor
- Biruni UniversityUniversity, hospital or other
- Study start
- 9 Jan 2023 (actual)
- Primary completion
- 29 Apr 2024 (actual)
- Study completion
- 29 Jul 2024 (actual)
- First posted
- 27 May 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Connective tissue graft operation is one of the most frequently performed surgical procedures to increase the width of the attached gingiva and to treat gingival recessions. The most preferred donor site during this operation is the palatal mucosa.Reported postoperative complications are usually related to the donor site. Problems such as prolongation of bleeding time, delay in wound healing and severe pain in the palatal region where the graft is taken are frequently encountered. Bleeding control in the palatal donor area is very important for patient comfort. Additional measures may be required to control bleeding, such as sutures with or without hemostatic agents, or acrylic, plastic palatal stents and periodontal pastes prepared before the operation. Suturing the Greater Palatine Artery (GPA) or terminal vessel branches has been shown to be an effective method to control palatal bleeding.
Therefore the aim of this study is to evaluate the effectiveness of the pre-suture method applied in the palatal region before the connective tissue graft is taken in reducing hemostasis.Pre-suture method can increase the operator's field of vision and operational comfort. Patient-reported outcomes such as the amount of pain and bleeding in the palatal donor area during and after surgery, painkiller intake, number of days of discomfort, satisfaction, quality of life, and willingness to be treated will be evaluated.
In addition, it will be evaluated whether this suture technique affects the healing of the half-thickness flap in the palatal region after obtaining a connective tissue graft with a single incision method.
Detailed description
Various methods have been described to manage bleeding and/or promote healing of the palatal donor site.These techniques include sutures with or without hemostatic agents, or the use of materials such as acrylic or plastic palatal stents, periodontal seals, and platelet-rich fibrin (PRF) prepared before the operation. The use of an additional hemostatic agent often requires additional surgical time and expense, and most of the techniques described in the literature for the management of palatal hemorrhage are used to control bleeding after it has occurred. GPA and/or suturing of terminal vessel branches is a popular and effective technique to control palatal bleeding.Recently, a detailed protocol for a Greater Palatine Compression Suture (GPCS) has been presented and proposed as a predictable method for controlling bleeding when this suture is applied preoperatively at the palatal donor site. This protocol is based on the estimated location of the greater palatal foramen and vascular bundle and has proven to be efficient in controlling palatal bleeding. The recommended protocol for GPCS is as follows:
- The midpalatal line is defined.
- An imaginary line is joined to the midpalatal line from the midline of the first and second maxillary molars (point X).
- Another point (Point A) is defined along the X line at a distance of 20 mm from the midpalatal line. (Y point)
- The needle is passed through point A along its curve, and the exit point (point B) of the needle should be approximately 10 mm medial and approximately 5 mm anterior to point A. 1/2 diameter, triangular body, 3-0 braided silk sutures recommended in this protocol were used. The effectiveness of GPCS on palatal hemostasis before obtaining a free gingival graft was also evaluated previously. Reduced palatal bleeding is a valuable clinical benefit in terms of reduced perioperative morbidity, better visibility for the operator, reduced need for hemostatic agents, and operation time.
In addition, the availability of such a technique can be reassuring to the operator when removing autogenous grafts and may be of additional importance in patients prone to bleeding. One of the primary results in our study was the amount of perioperative bleeding. Methods of measuring perioperative blood loss include direct volumetric estimation, weighing blood gauze pads, using various formulas based on hematocrit values, and visual estimation. In our study, bloody gauze pads will be measured with precision scales and the amount of bleeding in the palate will be directly measured during the operation.
In our study, it is aimed to evaluate whether the BPKS technique has any effect on the healing of the half-thickness flap in the donor area when applied in connective tissue graft procedures obtained with the single incision method.
Evaluation of donor site wound healing with anamnesis and index records will be performed by a blinded investigator who did not perform the operation (B.K.).
Initial periodontal treatments will be performed for each patient participating in the study before surgical procedures. Oral hygiene, scaling, root planing and occlusal adjustments will be carried out when necessary. Connective tissue graft will be harvested with a single incision method. Surgical procedures will be performed by a single investigator (M.Z.).
At the beginning of the operation, 0.5 mL of 2% lidocaine anesthesia containing 1:200,000 adrenaline will be administered to the palatal donor area to both the control and test groups, from the points corresponding to the canine and the first molar. In the test group, GPCS (Silk, 4-0, 18 mm, 3/8 sharp needle) will be placed before the incision in the palatal region. Then, connective tissue graft will be taken with a single incision technique using a 15-C scalpel in both groups. The thickness of the connective tissue graft to be taken in our study will be 1.5-2 mm, and its dimensions will be 8X8 mm as standard. Then, the half-thickness flap in the palatal region will be closed with a continuous locked suture (Trofilen, 5/0, 16 mm, 3/8 sharp needle). The connective tissue graft will be sutured to the recipient area with 6-0 polyglactin sutures (Pegalak rapid, 13 mm, 3/8 sharp needle) and the flap is shifted coronally (Trofilen, 5/0, 16 mm, 3/8 sharp needle) will be closed with. Measurement of blood loss will be carried out as described above.
There is no study that applies the BPKS technique during the connective tissue graft operation. In addition, patient-reported outcome measures such as painkiller intake, number of days of discomfort, satisfaction, quality of life, and willingness to be treated again, as well as the amount of pain and bleeding of the palatal donor site during and after surgery, were not examined.
The operation period will be started after the incision and will be terminated when the operation is completed. For postoperative care, the patient will be prescribed a mouthwash containing 0.12% chlorhexidine digluconate to be used twice a day for 3 weeks. In addition, analgesic (Flurbiprofen 100 mg film tablet) will be prescribed to be used when they feel pain. After the operation, patients will be asked not to brush the operation area for 2 weeks and patients will be warned to avoid hard chewing. Brushing with a soft brush will be required in the 3rd postoperative week. The suture in the donor area will be removed in the 1st week, and the suture in the recipient area will be removed in the 2nd week postoperatively. GPCS will be taken 1 week after the operation.
Patients will be called for controls on the 3rd day, 1st and 2nd weeks, 1st, 3rd and 6th months after the operation and their measurements will be recorded. The scales evaluated by the patient will be given to the patient after the operation and will be collected when the study is finished. The records that the physician should take after the surgery will always be recorded by a single researcher. The investigator who took the records will not know the surgical technique applied.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (investigator)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Palatal Pre-Suture (GPCS) | Experimental | Procedure: SutureIn the test group, GPCS (Silk, 4-0, 18 mm, 3/8 sharp needle) will be placed before the incision in the palatal region. GPCS will be taken one week after surgery. |
| No Palatal Suture (No GPCS) - Control | Active comparator | Procedure: No Suture CTG -ControlIn the control group, no sutures will be applied before graft harvesting from the palate. |
Who may qualify
- Ages
- 19 to 60 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (9 listed)
- - The patient must be over the age of 18,
- Not having any systemic disease,
- Not receiving chemotherapy or radiotherapy treatment,
- Not using drugs regularly and not being addicted to drugs,
- Not be in pregnancy and/or lactation period,
Key exclusion criteria (9 listed)
- The patient is younger than 18 years old,
- Active infectious disease (acute hepatitis, AIDS, tuberculosis), cancer or any systemic condition that may affect periodontal tissues,
- Receiving chemotherapy or radiotherapy treatment,
- Being on regular medication and being addicted to drugs,
- Patients with a plaque score greater than 20% after phase I treatment (Silness and Löe, 1964),
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| SutureThe pressure application will be applied before the incision on the palate. | Procedure or surgery | Palatal Pre-Suture (GPCS) |
| No Suture CTG -ControlA graft will be taken from the palate before the procedure is applied. | Procedure or surgery | No Palatal Suture (No GPCS) - Control |
Primary outcome
Measuring the Amount of Intra-operative Bleeding with a Precision Balance
Time frame: During surgery
In our study, the amount of blood lost will be estimated by using the gauze weight method, which is a method of directly estimating blood loss. All measurements will be made on a 1 g precision digital balance. Sterile gauze swabs will be weighed dry before the operation. The gauze pads that will be used later will be moistened with 10 mL of sterile 0.9 g/L saline solution before starting the procedure and the weight will be measured again. The time from the removal of the connective tissue graft to the end of the operation will be measured and the pre-moistened gauze pads will be used on the palate during this period and will be stored separately and their weight will be measured immediately after the operation is over. In this method, aspiration in the palatal region should be avoided to minimize errors in blood loss measurement.
Reporting of secondary bleeding as present/absent in the 1st postoperative week
Time frame: 1st postoperative week after the operation.
Reporting of secondary bleeding as present/absent both by the patient and by the physician in the follow-up appointments in the 1st postoperative weeks
patient discomfort and satisfaction [Oral Health Impact Profile ]
Time frame: On the 3rd day after the operation.
In this evaluation, the Oral Health Impact Profile (OHIP-14) test will be used by marking the patients on the 3rd postoperative day. Likert response system in the evaluation of the OHIP14 scale: 0: "never", 1. "very little" 2. "sometimes" 3. "quite often" 4. is rated as "often". The total score of the answers given by the participant to each item is evaluated by calculating. The total score is minimum 0, maximum 56. It is concluded that as the total score increases, the severity of the problem increases and the quality of life decreases.
Evaluation of the pain felt by the patients after the operation with Visual Analogue Scale
Time frame: 3rd day after the operation.
Pain scores will be recorded on the postoperative 3rd day. It is determined by the patient's assessment of the intensity of pain felt on a scale from 0 to 10. 0: No pain, 10: There is unbearable pain.
Reporting of secondary bleeding as present/absent in the 2nd postoperative week
Time frame: 2nd postoperative week after the operation.
Reporting of secondary bleeding as present/absent both by the patient and by the physician in the follow-up appointments in the 2nd postoperative weeks
patient discomfort and satisfaction [Oral Health Impact Profile ]
Time frame: 1st week after the operation.
In this evaluation, the Oral Health Impact Profile (OHIP-14) test will be used by marking the patients on the 1st postoperative week. Likert response system in the evaluation of the OHIP14 scale: 0: "never", 1. "very little" 2. "sometimes" 3. "quite often" 4. is rated as "often". The total score of the answers given by the participant to each item is evaluated by calculating. The total score is minimum 0, maximum 56. It is concluded that as the total score increases, the severity of the problem increases and the quality of life decreases.
patient discomfort and satisfaction [Oral Health Impact Profile ]
Time frame: 2nd week after the operation.
In this evaluation, the Oral Health Impact Profile (OHIP-14) test will be used by marking the patients on the 2nd postoperative week. Likert response system in the evaluation of the OHIP14 scale: 0: "never", 1. "very little" 2. "sometimes" 3. "quite often" 4. is rated as "often". The total score of the answers given by the participant to each item is evaluated by calculating. The total score is minimum 0, maximum 56. It is concluded that as the total score increases, the severity of the problem increases and the quality of life decreases.
patient discomfort and satisfaction [Oral Health Impact Profile ]
Time frame: 4th week after the operation.
In this evaluation, the Oral Health Impact Profile (OHIP-14) test will be used by marking the patients on the 4th postoperative week. Likert response system in the evaluation of the OHIP14 scale: 0: "never", 1. "very little" 2. "sometimes" 3. "quite often" 4. is rated as "often". The total score of the answers given by the participant to each item is evaluated by calculating. The total score is minimum 0, maximum 56. It is concluded that as the total score increases, the severity of the problem increases and the quality of life decreases.
Evaluation of the pain felt by the patients after the operation with Visual Analogue Scale
Time frame: 1st week after the operation.
Pain scores will be recorded on the postoperative 1st week by marking the Visual Analogue Scale (VAS). It will be determined on a scale from 0 (no pain) to 10 (unbearable pain). It is determined by the patient's assessment of the intensity of pain felt on a scale from 0 to 10. 0: No pain 10: There is unbearable pain
Evaluation of the pain felt by the patients after the operation with Visual Analogue Scale.
Time frame: 2nd week after the operation.
Pain scores will be recorded on the postoperative 2nd week by marking the Visual Analogue Scale (VAS). It will be determined on a scale from 0 (no pain) to 10 (unbearable pain). It is determined by the patient's assessment of the intensity of pain felt on a scale from 0 to 10. 0: No pain, 10: There is unbearable pain.
Evaluation of the pain felt by the patients after the operation with Visual Analogue Scale
Time frame: 4th week after the operation.
Pain scores will be recorded on the postoperative 4th week by marking the Visual Analogue Scale (VAS). It will be determined on a scale from 0 (no pain) to 10 (unbearable pain). It is determined by the patient's assessment of the intensity of pain felt on a scale from 0 to 10. 0: No pain, 10: There is unbearable pain.
8 secondary outcomes
Evaluation of palatal wound healing by measuring the Early Wound Healing Index in the first 3 months after the operation
Time frame: 3rd day after surgery.
Findings of necrosis on the donor area
Time frame: During and first 3 months after surgery
Findings of healing with complications on the donor area
Time frame: During and first 3 months after surgery
Evaluation of palatal wound healing by measuring the Early Wound Healing Index
Time frame: 1st week after surgery.
Evaluation of palatal wound healing by measuring the Early Wound Healing Index
Time frame: 2nd week after surgery.
Evaluation of palatal wound healing by measuring the Early Wound Healing Index
Time frame: 1st month after surgery.
Findings of necrosis on the donor area
Time frame: During and first 3 months after surgery
Findings of healing with complications on the donor area
Time frame: During and first 3 months after surgery
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Jan 2026.
- Individual participant dataSharing planned: No
Related trials for Suture, Complication
RecruitingObservational study
Evaluation of Survival and Clinical Outcomes of Patients Treated With Isolated All-inside Meniscal Sutures or With Meniscal Sutures Associated With Ligament Reconstruction
Suture, Complication, Ligament Laceration
Recruiting
abSorbable vErsus Non-absorbable SuturEs for Wound Closure in Carpal Tunnel Release
Carpal Tunnel Syndrome, Wound Infection
Recruiting
Influence of Suture Type on Emergency Midline Laparotomy Closure
Linea Alba Hernia, Evisceration; Operation Wound
Recruiting
SCI-Pex Study - Safety and Performance of PexyEazy®, a Device for Treatment of Hemorrhoids
Hemorrhoids, Hemorrhoids, Internal
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Burcu Karaduman principal investigator
bkaraduman@biruni.edu.tr
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Suture in people with Suture, Complication and Gingival Recession, run by Biruni University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 9 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 7 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Measuring the Amount of Intra-operative Bleeding with a Precision Balance (time frame: During surgery). The study lists 11 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jan 2026; AzTrials last refreshed its copy on 7 Nov 2026.